Japan Branded Generics Market Size & Outlook, 2026-2033
- Pharmaceuticals
- Metabolic Disorders Treatment
- Branded Generics Market Outlook
- Metabolic Disorders Treatment
Global Market
Related Markets
Ask a question about the branded generics market
Japan branded generics market highlights
- The Japan branded generics market generated a revenue of USD 10,073.4 million in 2025 and is expected to reach USD 15,173.5 million by 2033.
- The Japan market is expected to grow at a CAGR of 5.4% from 2026 to 2033.
- In terms of segment, oral was the largest revenue generating route of administration in 2025.
- Parenteral is the most lucrative route of administration segment registering the fastest growth during the forecast period.
Branded generics market data book summary
| Market revenue in 2025 | USD 10,073.4 million |
| Market revenue in 2033 | USD 15,173.5 million |
| Growth rate | 5.4% (CAGR from 2026 to 2033) |
| Largest segment | Oral |
| Fastest growing segment | Parenteral |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Topical, Oral, Parenteral, Others Route of Administration |
| Key market players worldwide | Teva Pharmaceutical Industries Ltd, Lupin, Sanofi SA, Sun Pharmaceutical Industries, Dr. Reddy’s Laboratories, GlaxoSmithKline, Pfizer Inc, Apotex Inc., Viatris Inc |
Other key industry trends
- In terms of revenue, Japan accounted for 3.6% of the global branded generics market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China branded generics market is projected to lead the regional market in terms of revenue in 2033.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 53,386.1 million by 2033.
Japan is one of the largest manufacturers of generic pharmaceuticals, which represents the world’s eighth largest market in terms of value. The growing geriatric population has increased the medical expenditure in the country.
To reduce the healthcare expenses, a cabinet decision was passed in 2015 with an aim to achieve generic drugs share of around 80% by September 2020. Due to the government efforts for higher use of generics, certain players are expanding their geographical presence and focusing on export of Japanese quality standard products back to their country to gain considerable profit margin.
Moreover, the drug pricing policy of the country is attractive for generic manufacturers, helping them establish their presence in the market. The National Health Insurance System in Japan sets the reimbursement price of generic drugs and biosimilar at 50% or less & 70%, respectively, than the originator drug.
No credit card required*
Publish Date: Jan 16, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Branded Generics Market Scope
Branded Generics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Teva Pharmaceutical Industries Ltd | View profile | 37,851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | www.tevapharm.com |
| Pfizer Inc | View profile | 88,000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | www.pfizer.com |
| Sanofi SA | View profile | 87,994 | 46, avenue de la Grande Armée, Paris, France, 75017 | www.sanofi.com |
| Lupin | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | www.lupin.com |
| Sun Pharmaceutical Industries | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | www.sunpharma.com |
| Dr. Reddy’s Laboratories | View profile | 10001+ | Hyderabad, Andhra Pradesh, India, Asia | www.drreddys.com/ |
| Viatris Inc | View profile | 38,000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | www.viatris.com |
| GlaxoSmithKline | View profile | 10001+ | London, England, United Kingdom, Europe | www.gsk.com |
| Apotex Inc. | View profile | 10001+ | Toronto, Ontario, Canada, North America | www.apotex.com |
Japan Branded Generics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Branded Generics Market Outlook will help companies and investors design strategic landscapes.
Oral was the largest segment with a revenue share of 62.05% in 2025.
Horizon Databook has segmented the Japan branded generics market based on topical, oral, parenteral, others route of administration covering the revenue growth of each sub-segment from 2021 to 2033.
Japan is one of the largest manufacturers of generic pharmaceuticals, which represents the world’s eighth largest market in terms of value. The growing geriatric population has increased the medical expenditure in the country.
To reduce the healthcare expenses, a cabinet decision was passed in 2015 with an aim to achieve generic drugs share of around 80% by September 2020. Due to the government efforts for higher use of generics, certain players are expanding their geographical presence and focusing on export of Japanese quality standard products back to their country to gain considerable profit margin.
Moreover, the drug pricing policy of the country is attractive for generic manufacturers, helping them establish their presence in the market. The National Health Insurance System in Japan sets the reimbursement price of generic drugs and biosimilar at 50% or less & 70%, respectively, than the originator drug.
- Japan Branded Generics Market Route of Administration Outlook (Revenue, USD Million , 2021-2033)
- Topical
- Oral
- Parenteral
- Others Route of Administration
- Japan Branded Generics Market Application Outlook (Revenue, USD Million , 2021-2033)
- Neurological Diseases
- Others Application
- Cardiovascular Diseases
- Dermatological diseases
- Oncology
- Gastrointestinal Diseases
- Acute and Chronic Pain
- Japan Branded Generics Market Drug Class Outlook (Revenue, USD Million , 2021-2033)
- Alkylating Agents
- Hormones
- Others Drug Class
- Anti-hypertensive
- Lipid Lowering drugs
- Anti-psychotics
- Antimetabolites
- Anti-depressants
- Anti-epileptics
- Japan Branded Generics Market Distribution Channel Outlook (Revenue, USD Million , 2021-2033)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy & Others
Reasons to subscribe to Branded Generics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Branded Generics Market Outlook databook
- Our clientele includes a mix of Branded Generics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan Branded Generics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Japan Branded Generics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Japan Branded Generics Market, 2021-2033 (US$M)
Japan branded generics market statistics, by route of administration, 2021-2033 (US$M)
